Jennifer McNealey
Director/Board Member at ANTIBE THERAPEUTICS INC.
Net worth: 5 441 $ as of 2024-04-29
Jennifer McNealey active positions
| Companies | Position | Start | End |
|---|---|---|---|
| ANTIBE THERAPEUTICS INC. | Director/Board Member | 2020-11-23 | - |
| Independent Dir/Board Member | 2020-11-23 | - | |
| CONDUIT PHARMACEUTICALS INC. | Director/Board Member | 2023-09-21 | - |
| Independent Dir/Board Member | 2023-09-21 | - | |
Abdera Therapeutics, Inc.
 Abdera Therapeutics, Inc. BiotechnologyHealth Technology Abdera Therapeutics, Inc. is a Canadian precision oncology company that operates in the field of cancer treatment. The CEO of the company is Lana Elizabeth Janes. | Director of Finance/CFO | - | - |
Career history of Jennifer McNealey
Former positions of Jennifer McNealey
| Companies | Position | Start | End |
|---|---|---|---|
| TELESIS BIO, INC. | Director of Finance/CFO | 2015-01-31 | 2022-07-07 |
| ENZON PHARMACEUTICALS, INC. | Director/Board Member | 2013-09-24 | 2021-10-31 |
| Independent Dir/Board Member | 2013-09-24 | 2021-10-31 | |
| Laurient LLC | Founder | 2004-12-31 | 2011-12-31 |
Franklin Advisers, Inc.
 Franklin Advisers, Inc. Investment ManagersFinance Franklin Advisers, Inc. is a mutual fund manager and registered investment advisor headquartered in San Mateo, California. The firm was founded in 1985 and is a subsidiary of Franklin Resources, Inc. (NYSE: BEN), a holding company that, together with its various subsidiaries is referred to as Franklin Templeton Investments. Franklin Advisers provides investment advisory and portfolio management services to US and non-US, registered open-end and closed-end funds and unregistered funds, as well as separate accounts. | Analyst-Equity | - | 2005-07-31 |
| Portfolio Manager-Equities | - | 2005-07-31 | |
| Morgan Stanley Dean Witter Advisors, Inc. | Corporate Officer/Principal | - | - |
| Paramount Capital, Inc. | Corporate Officer/Principal | - | - |
| ░░░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - | |
| ░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
| ░░░░░░ ░░░░ ░ ░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Training of Jennifer McNealey
| Cornell University | Graduate Degree |
Statistics
International
| United States | 12 |
| Canada | 3 |
Operational
| Corporate Officer/Principal | 4 |
| Director/Board Member | 3 |
| Independent Dir/Board Member | 3 |
Sectoral
| Health Technology | 6 |
| Finance | 4 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 5 |
|---|---|
| ENZON PHARMACEUTICALS, INC. | Health Technology |
| CALITHERA BIOSCIENCES, INC. | Health Technology |
| ANTIBE THERAPEUTICS INC. | Health Technology |
| TELESIS BIO, INC. | Commercial Services |
| CONDUIT PHARMACEUTICALS INC. | Health Technology |
| Private companies | 7 |
|---|---|
Amerindo Investment Advisors, Inc.
 Amerindo Investment Advisors, Inc. Investment ManagersFinance Amerindo Investment Advisors Inc. is a San Francisco-based firm that manages institutional portfolios having a focus on Internet and Internet related issuers. The firm's separate account business consists of corporate ERISA plans, public pension plans, endowments, foundations, family trusts and high net worth individuals. Amerindo mutual funds are offered for the investor seeking a concentration in emerging technology with a focus on the Internet, health sciences and biotechnology. | Finance |
| Paramount Capital, Inc. | |
Franklin Advisers, Inc.
Franklin Advisers, Inc. Investment ManagersFinance Franklin Advisers, Inc. is a mutual fund manager and registered investment advisor headquartered in San Mateo, California. The firm was founded in 1985 and is a subsidiary of Franklin Resources, Inc. (NYSE: BEN), a holding company that, together with its various subsidiaries is referred to as Franklin Templeton Investments. Franklin Advisers provides investment advisory and portfolio management services to US and non-US, registered open-end and closed-end funds and unregistered funds, as well as separate accounts. | Finance |
| Weiss, Peck & Greer LLC | Finance |
| Morgan Stanley Dean Witter Advisors, Inc. | |
| Laurient LLC | |
Abdera Therapeutics, Inc.
Abdera Therapeutics, Inc. BiotechnologyHealth Technology Abdera Therapeutics, Inc. is a Canadian precision oncology company that operates in the field of cancer treatment. The CEO of the company is Lana Elizabeth Janes. | Health Technology |
- Stock Market
- Insiders
- Jennifer McNealey
- Experience
